Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain - Top-Institutions - MDSpire

Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain

  • By

  • Sina M. Pütz

  • Marie Engelhard

  • Sebastian M. Wingen-Heimann

  • David F. Brilz

  • Brune Akrich

  • Heike Kohl

  • Annika Y. Classen

  • Carlota Gudiol

  • Enric Sastre-Escola

  • Franziska C. Trudzinski

  • Arturo Olivares Rivera

  • Eva Lücke

  • Tadeusz Marczewski

  • Ayham Daher

  • Stephan Eisenmann

  • Jacqueline Schmitz

  • Anke Reinacher-Schick

  • Julia von Tresckow

  • Rebekka Mispelbaum

  • Tessa Hattenhauer

  • J. Janne Vehreschild

  • May 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University Hospital Cologne
    University Hospital Cologne

    Cologne, North Rhine-Westphalia

    Key Differentiators

    • Pulmonology

  • #2

    Geneva University Hospitals
    Geneva University Hospitals

    Geneva, Geneva

    Key Differentiators

    • Pulmonology

  • #3

    CAPNETZ study project
    CAPNETZ study project

    Multiple Locations, N/A

    Key Differentiators

    • Pulmonology

Original Source(s)

Prognosis and aetiology of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in patients with active lung or lower head and neck cancer (PEPP-C): a retrospective, matched multicentre cohort study in Germany and Spain

  • by Sina M. Pütz, Marie Engelhard, Sebastian M. Wingen-Heimann, David F. Brilz, Brune Akrich, Heike Kohl, Annika Y. Classen, Carlota Gudiol, Enric Sastre-Escola, Franziska C. Trudzinski, Arturo Olivares Rivera, Eva Lücke, Tadeusz Marczewski, Ayham Daher, Stephan Eisenmann, Jacqueline Schmitz, Anke Reinacher-Schick, Julia von Tresckow, Rebekka Mispelbaum, Tessa Hattenhauer, J. Janne Vehreschild

  • May 4, 2026

Related Content

Progression-directed ablative radiotherapy improves event-free survival in oligoprogressive NSCLC

Non-invasive radiogenomic mapping of the SMARCAL1-driven ferroptotic niche is associated with longitudinal MRD-negative surveillance in early-stage NSCLC

Successful management of severe Pneumocystis jirovecii pneumonia with inhaled nitric oxide and individualized ventilatory strategies in an immunosuppressed patient: a case report